Phase
Condition
N/ATreatment
temozolomide
S-1
capecitabine
Clinical Study ID
Ages > 16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participant who is being treated with ONO-4538 as monotherapy or in Combination withOther Therapies in clinical trials
- Participant who is eligible for ONO-4538 monotherapy or in combination with othertherapies as per the clinical trials, and/or investigator-assessed clinical benefit
Exclusion
Exclusion Criteria:
- Participant judged to be incapable of providing consent for reasons such as concurrentdementia
- Participant judged by the investigator to be inappropriate as participants of thisstudy
Study Design
Connect with a study center
Chiba Clinical Site1
Kashiwa, Chiba
JapanActive - Recruiting
Ehime Clinical Site1
Matsuyama, Ehime
JapanCompleted
Fukuoka Clinical Site1
Kurume, Fukuoka
JapanActive - Recruiting
Hokkaido Clinical Site1
Sapporo, Hokkaido
JapanActive - Recruiting
Hyogo Clinical Site1
Akashi, Hyogo
JapanActive - Recruiting
Kanagawa Clinical Site1
Yokohama, Kanagawa
JapanActive - Recruiting
Oita Clinical Site1
Yufu, Oita
JapanActive - Recruiting
Osaka Clinical Site1
Suita, Osaka
JapanActive - Recruiting
Osaka Clinical Site3
Takatsuki, Osaka
JapanActive - Recruiting
Saitama Clinical Site1
Hidaka, Saitama
JapanActive - Recruiting
Saitama Clinical Site2
Kitaadachi-gun, Saitama
JapanActive - Recruiting
Tokyo Clinical Site3
Bunkyo-ku, Tokyo
JapanActive - Recruiting
Tokyo Clinical Site2
Chuo-ku, Tokyo
JapanActive - Recruiting
Tokyo Clinical Site1
Koto-ku, Tokyo
JapanActive - Recruiting
Tokyo Clinical Site4
Shinjuku-ku, Tokyo
JapanActive - Recruiting
Chiba Clinical Site2
Chiba,
JapanActive - Recruiting
Fukuoka Clinical Site2
Fukuoka,
JapanActive - Recruiting
Fukuoka Clinical Site3
Fukuoka,
JapanActive - Recruiting
Hiroshima Clinical Site1
Hiroshima,
JapanActive - Recruiting
Kyoto Clinical Site1
Kyoto,
JapanActive - Recruiting
Okayama Clinical Site1
Okayama,
JapanActive - Recruiting
Osaka Clinical Site2
Osaka,
JapanActive - Recruiting
Daegu Clinical Site1
Daegu,
Korea, Republic ofActive - Recruiting
Gyeonggi-do Clinical site1
Gyeonggi-do,
Korea, Republic ofActive - Recruiting
Incheon Clinical Site1
Incheon,
Korea, Republic ofActive - Recruiting
Seoul Clinical Site1
Seoul,
Korea, Republic ofActive - Recruiting
Seoul Clinical Site2
Seoul,
Korea, Republic ofCompleted
Seoul Clinical Site3
Seoul,
Korea, Republic ofActive - Recruiting
Seoul Clinical Site4
Seoul,
Korea, Republic ofActive - Recruiting
Seoul Clinical Site5
Seoul,
Korea, Republic ofActive - Recruiting
Seoul Clinical Site6
Seoul,
Korea, Republic ofActive - Recruiting
Kaohsiung Clinical Site1
Kaohsiung,
TaiwanCompleted
Kaohsiung Clinical Site2
Kaohsiung,
TaiwanCompleted
Tainan Clinical Site1
Tainan,
TaiwanActive - Recruiting
Tainan Clinical Site2
Tainan,
TaiwanActive - Recruiting
Taipei Clinical Site1
Taipei,
TaiwanActive - Recruiting
Taipei Clinical Site2
Taipei,
TaiwanActive - Recruiting
Taoyuan Clinical Site1
Taoyuan,
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.